These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7488232)

  • 21. Regulation of endothelial cell protein C activation by native and oxidized low density lipoprotein.
    Wilson BD; Pitas RE; Rodgers GM
    Semin Thromb Hemost; 1992 Jan; 18(1):11-7. PubMed ID: 1574712
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LPC in oxidized LDL elicits vasocontraction and inhibits endothelium- dependent relaxation.
    Murohara T; Kugiyama K; Ohgushi M; Sugiyama S; Ohta Y; Yasue H
    Am J Physiol; 1994 Dec; 267(6 Pt 2):H2441-9. PubMed ID: 7810742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of oxidized low- and high-density lipoproteins on gene expression of human macrophages.
    Levula M; Jaakkola O; Luomala M; Nikkari ST; Lehtimäki T
    Scand J Clin Lab Invest; 2006; 66(6):497-508. PubMed ID: 17000557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxidized lipoprotein(a) inhibits endothelium-dependent dilation: prevention by high density lipoprotein.
    Galle J; Bengen J; Schollmeyer P; Wanner C
    Eur J Pharmacol; 1994 Nov; 265(1-2):111-5. PubMed ID: 7883023
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of inducible nitric oxide synthase in macrophages by oxidized low-density lipoproteins.
    Yang X; Cai B; Sciacca RR; Cannon PJ
    Circ Res; 1994 Feb; 74(2):318-28. PubMed ID: 7507415
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxidized low-density lipoprotein increases superoxide production by endothelial nitric oxide synthase by inhibiting PKCalpha.
    Fleming I; Mohamed A; Galle J; Turchanowa L; Brandes RP; Fisslthaler B; Busse R
    Cardiovasc Res; 2005 Mar; 65(4):897-906. PubMed ID: 15721870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of simvastatin on endothelium-dependent vaso-relaxation and endogenous nitric oxide synthase inhibitor.
    Jiang JL; Jiang DJ; Tang YH; Li NS; Deng HW; Li YJ
    Acta Pharmacol Sin; 2004 Jul; 25(7):893-901. PubMed ID: 15210062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Native low-density lipoprotein increases endothelial cell nitric oxide synthase generation of superoxide anion.
    Pritchard KA; Groszek L; Smalley DM; Sessa WC; Wu M; Villalon P; Wolin MS; Stemerman MB
    Circ Res; 1995 Sep; 77(3):510-8. PubMed ID: 7543827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paradoxical increase in nitric oxide synthase activity in hypercholesterolaemic rats with impaired renal function and decreased activity of nitric oxide.
    Rahman MM; Varghese Z; Moorhead JF
    Nephrol Dial Transplant; 2001 Feb; 16(2):262-8. PubMed ID: 11158398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro oxidised HDL exerts a cytotoxic effect on macrophages.
    Hurtado I; Fiol C; Gracia V; Caldú P
    Atherosclerosis; 1996 Aug; 125(1):39-46. PubMed ID: 8831925
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-density lipoprotein antagonizes oxidized low-density lipoprotein by suppressing oxygen free-radical formation and preserving nitric oxide bioactivity.
    Lee CM; Chien CT; Chang PY; Hsieh MY; Jui HY; Liau CS; Hsu SM; Lee YT
    Atherosclerosis; 2005 Dec; 183(2):251-8. PubMed ID: 16098532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Probucol preserves endothelial function by reduction of the endogenous nitric oxide synthase inhibitor level.
    Jiang JL; Li Ns NS; Li YJ; Deng HW
    Br J Pharmacol; 2002 Mar; 135(5):1175-82. PubMed ID: 11877324
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inactivation of endothelial derived relaxing factor by oxidized lipoproteins.
    Chin JH; Azhar S; Hoffman BB
    J Clin Invest; 1992 Jan; 89(1):10-8. PubMed ID: 1309534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oxidized low-density lipoprotein decreases the expression of endothelial nitric oxide synthase.
    Liao JK; Shin WS; Lee WY; Clark SL
    J Biol Chem; 1995 Jan; 270(1):319-24. PubMed ID: 7529227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oxidized low-density lipoprotein regulates matrix metalloproteinase-9 and its tissue inhibitor in human monocyte-derived macrophages.
    Xu XP; Meisel SR; Ong JM; Kaul S; Cercek B; Rajavashisth TB; Sharifi B; Shah PK
    Circulation; 1999 Mar; 99(8):993-8. PubMed ID: 10051290
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oxidative modification of low-density lipoproteins and the inhibition of relaxations mediated by endothelium-derived nitric oxide in rabbit aorta.
    Plane F; Bruckdorfer KR; Kerr P; Steuer A; Jacobs M
    Br J Pharmacol; 1992 Jan; 105(1):216-22. PubMed ID: 1596684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variable effects of L-arginine analogs on L-arginine-nitric oxide pathway in human neutrophils and platelets may relate to different nitric oxide synthase isoforms.
    Chen LY; Mehta JL
    J Pharmacol Exp Ther; 1996 Jan; 276(1):253-7. PubMed ID: 8558439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oxidized low-density lipoprotein-induced CD147 expression and its inhibition by high-density lipoprotein on platelets in vitro.
    Yang SH; Li YT; Du DY
    Thromb Res; 2013; 132(6):702-11. PubMed ID: 24144446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of SIN-1 and sodium nitroprusside (NANP) on ox-LDL metabolism in macrophages.
    Wybrańska I; Miszczuk-Jamska B; Baczyńska E; Goldsztajn P; Sowa G; Przewłocki R; Gryglewski R; Dembińska-Kieć A
    J Physiol Pharmacol; 1994 Sep; 45(3):387-97. PubMed ID: 7841451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Klotho ameliorates oxidized low density lipoprotein (ox-LDL)-induced oxidative stress via regulating LOX-1 and PI3K/Akt/eNOS pathways.
    Yao Y; Wang Y; Zhang Y; Liu C
    Lipids Health Dis; 2017 Apr; 16(1):77. PubMed ID: 28407763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.